Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.
Hassane Mchaourab, Ph.D., professor of Molecular Physiology & Biophysics, Physics and Chemistry, has been named the new director of the Ph.D.-granting Chemical and Physical Biology (CPB) program at Vanderbilt University.
Congress has not yet figured out how to reduce the national debt without slashing health care spending and research. How will Vanderbilt University Medical Center respond?
R. Alto Charo, J.D., a nationally known bioethicist at the University of Wisconsin Law School in Madison, will deliver the first Flexner Discovery Lecture on Thursday, Sept. 20.